Evidence map›Paper›PMID 23996004›Full record

ArticleBritish journal of sports medicine2014

Substance P reduces TNF-α-induced apoptosis in human tenocytes through NK-1 receptor stimulation.

Ludvig J Backman, Daniella E Eriksson, Patrik Danielson

Open access · hybridAbstract read
In one paragraph

Article in British journal of sports medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Musculoskeletal Consequences of COVID-19.The Journal of bone and joint surgery. American volume · 2020
    Article
  8. Article
  9. PeerJ · 2019
    Article
  10. Article
  11. A Protocol to Acquire the Degenerative Tenocyte from Humans.Journal of visualized experiments : JoVE · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ludvig J BackmanDepartment of Integrative Medical Biology, Anatomy, Umeå University, Umeå, Sweden Department of Surgical and Perioperative Sciences, Sports Medicine, Umeå University, Umeå, Sweden.
Daniella E ErikssonDepartment of Integrative Medical Biology, Anatomy, Umeå University, Umeå, Sweden.
Patrik DanielsonDepartment of Integrative Medical Biology, Anatomy, Umeå University, Umeå, Sweden.
Umeå University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been hypothesised that an upregulation of the neuropeptide substance P (SP) and its preferred receptor, the neurokinin-1 receptor (NK-1 R), is a causative factor in inducing tenocyte hypercellularity, a characteristic of tendinosis, through both proliferative and antiapoptotic stimuli. We have demonstrated earlier that SP stimulates proliferation of human tenocytes in culture.

aimThe aim of this study was to investigate whether SP can mediate an antiapoptotic effect in tumour necrosis factor-α (TNF-α)-induced apoptosis of human tenocytes in vitro.

resultsA majority (approximately 75%) of tenocytes in culture were immunopositive for TNF Receptor-1 and TNF Receptor-2. Exposure of the cells to TNF-α significantly decreased cell viability, as shown with crystal violet staining. TNF-α furthermore significantly increased the amount of caspase-10 and caspase-3 mRNA, as well as both BID and cleaved-poly ADP ribosome polymerase (c-PARP) protein. Incubation of SP together with TNF-α resulted in a decreased amount of BID and c-PARP, and in a reduced lactate dehydrogenase release, as compared to incubation with TNF-α alone. The SP effect was blocked with a NK-1 R inhibitor. DISCUSSION: This study shows that SP, through stimulation of the NK-1 R, has the ability to reduce TNF-α-induced apoptosis of human tenocytes. Considering that SP has previously been shown to stimulate tenocyte proliferation, the study confirms SP as a potent regulator of cell-turnover in tendon tissue, capable of stimulating hypercellularity through different mechanisms. This gives further support for the theory that the upregulated amount of SP seen in tendinosis could contribute to hypercellularity.

Indexed as

Achilles TendonApoptosisBH3 Interacting Domain Death Agonist ProteinCaspasesCells, CulturedCell SurvivalDose-Response Relationship, DrugHumansNeurokinin-1 Receptor AntagonistsNeurotransmitter AgentsPoly(ADP-ribose) PolymerasesReceptors, Neurokinin-1Receptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRNA, MessengerSubstance PBH3 Interacting Domain Death Agonist ProteinCaspasesNeurokinin-1 Receptor AntagonistsNeurotransmitter AgentsPoly(ADP-ribose) PolymerasesReceptors, Neurokinin-1Receptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRNA, MessengerSubstance PTumor Necrosis Factor-alphaAchilles TendonTendons

Identifiers

PMID23996004
PMCPMC4173875
OpenAlexW2139162154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.